These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15380200)

  • 21. Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
    Xi N; Bo Y; Doherty EM; Fotsch C; Gavva NR; Han N; Hungate RW; Klionsky L; Liu Q; Tamir R; Xu S; Treanor JJ; Norman MH
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5211-7. PubMed ID: 16203144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Citral derived amides as potent bacterial NorA efflux pump inhibitors.
    Thota N; Koul S; Reddy MV; Sangwan PL; Khan IA; Kumar A; Raja AF; Andotra SS; Qazi GN
    Bioorg Med Chem; 2008 Jul; 16(13):6535-43. PubMed ID: 18524600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3.
    Angell RM; Atkinson FL; Brown MJ; Chuang TT; Christopher JA; Cichy-Knight M; Dunn AK; Hightower KE; Malkakorpi S; Musgrave JR; Neu M; Rowland P; Shea RL; Smith JL; Somers DO; Thomas SA; Thompson G; Wang R
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1296-301. PubMed ID: 17194588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient asymmetric synthesis of P-chiral phosphine oxides via properly designed and activated benzoxazaphosphinine-2-oxide agents.
    Han ZS; Goyal N; Herbage MA; Sieber JD; Qu B; Xu Y; Li Z; Reeves JT; Desrosiers JN; Ma S; Grinberg N; Lee H; Mangunuru HP; Zhang Y; Krishnamurthy D; Lu BZ; Song JJ; Wang G; Senanayake CH
    J Am Chem Soc; 2013 Feb; 135(7):2474-7. PubMed ID: 23369026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent, selective MCH-1 receptor antagonists.
    Erickson SD; Banner B; Berthel S; Conde-Knape K; Falcioni F; Hakimi I; Hennessy B; Kester RF; Kim K; Ma C; McComas W; Mennona F; Mischke S; Orzechowski L; Qian Y; Salari H; Tengi J; Thakkar K; Taub R; Tilley JW; Wang H
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1402-6. PubMed ID: 18243691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR.
    Deak HL; Newcomb JR; Nunes JJ; Boucher C; Cheng AC; DiMauro EF; Epstein LF; Gallant P; Hodous BL; Huang X; Lee JH; Patel VF; Schneider S; Turci SM; Zhu X
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1172-6. PubMed ID: 18083554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents.
    Li J; Bertinato P; Cheng H; Cole BM; Bronk BS; Jaynes BH; Hickman A; Haven ML; Kolosko NL; Barry CJ; Manion TB
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3039-42. PubMed ID: 16529928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase.
    Marson CM; Mahadevan T; Dines J; Sengmany S; Morrell JM; Alao JP; Joel SP; Vigushin DM; Charles Coombes R
    Bioorg Med Chem Lett; 2007 Jan; 17(1):136-41. PubMed ID: 17046252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and structure-activity relationship of simple bis-amides as potent inhibitors of GlyT1.
    Jolidon S; Alberati D; Dowle A; Fischer H; Hainzl D; Narquizian R; Norcross R; Pinard E
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5533-6. PubMed ID: 18805008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oleate-mediated stimulation of microsomal triglyceride transfer protein (MTP) gene promoter: implications for hepatic MTP overexpression in insulin resistance.
    Qiu W; Taghibiglou C; Avramoglu RK; Van Iderstine SC; Naples M; Ashrafpour H; Mhapsekar S; Sato R; Adeli K
    Biochemistry; 2005 Mar; 44(8):3041-9. PubMed ID: 15723548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone.
    Kung PP; Funk L; Meng J; Collins M; Zhou JZ; Johnson MC; Ekker A; Wang J; Mehta P; Yin MJ; Rodgers C; Davies JF; Bayman E; Smeal T; Maegley KA; Gehring MR
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6273-8. PubMed ID: 18929486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
    Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
    J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of benzothiazole derivatives as efficacious and enterocyte-specific MTP inhibitors.
    Vu CB; Milne JC; Carney DP; Song J; Choy W; Lambert PD; Gagne DJ; Hirsch M; Cote A; Davis M; Lainez E; Meade N; Normington K; Jirousek MR; Perni RB
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1416-20. PubMed ID: 19181526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
    Flyrén K; Bergquist LO; Castro VM; Fotsch C; Johansson L; St Jean DJ; Sutin L; Williams M
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3421-5. PubMed ID: 17442567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice.
    Oliveira CP; Alves VA; Lima VM; Stefano JT; Debbas V; Sá SV; Wakamatsu A; Corrêa-Giannella ML; de Mello ES; Havaki S; Tiniakos DG; Marinos E; de Oliveira MG; Giannella-Neto D; Laurindo FR; Caldwell S; Carrilho FJ
    Biochem Pharmacol; 2007 Jul; 74(2):290-7. PubMed ID: 17524368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors.
    Tsai TY; Coumar MS; Hsu T; Hsieh HP; Chien CH; Chen CT; Chang CN; Lo YK; Wu SH; Huang CY; Huang YW; Wang MH; Wu HY; Lee HJ; Chen X; Chao YS; Jiaang WT
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3268-72. PubMed ID: 16581245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramides.
    Maw GN; Stobie A; Planken S; Pryde DC; Sanderson V; Platts MY; Corless M; Stacey P; Wayman C; Van Der Graaf P; Kohl C; Coggon S; Beaumont K
    Chem Biol Drug Des; 2006 Jan; 67(1):74-7. PubMed ID: 16492151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.